Wockhardt Ltd.
NSE: WOCKPHARMA | BSE: 532300
₹1,937.50
₹16.60
(0.86%)
As on 08-Jun-2026 09:39IST
Market cap
₹31,201 Cr
Revenue (TTM)
₹3,373 Cr
P/E Ratio
146.5
P/B Ratio
6.3
Div. Yield
0 %
Quality Score
1/10
Growth Score
5/10
Valuation Score
3/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹213 Cr
-
ROE
-1.5 %
-
ROCE
4.1 %
-
Industry P/E
44.87
-
EV/EBITDA
43.3
-
Debt to Equity
0.3
-
Book Value
₹304.1
-
EPS
₹17.4
-
Face value
5
-
Shares outstanding
162,492,169
10 Years Aggregate
CFO
₹1,178.86 Cr
EBITDA
₹1,278.89 Cr
Net Profit
₹-2,817.04 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Wockhardt
| 34.0 | 18.3 | 49.1 | 28.7 | 125.0 | 26.4 | 8.5 |
|
BSE Healthcare
| 8.2 | 1.3 | 7.8 | 8.7 | 24.3 | 13.6 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Wockhardt
| -0.7 | 201.6 | 90.2 | -41.2 | -24.1 | 132.6 | -55.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Wockhardt
|
1,937.5 | 31,200.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 146.5 | 6.3 |
| 3,391.6 | 27,250.0 | 1,339.4 | 356.4 | 33.2 | 23.2 | 76.5 | 16.5 | |
| 736.1 | 14,485.7 | 7,344.9 | 670.6 | 10.9 | 13.7 | 21.5 | 2.6 | |
| 424.6 | 16,486.7 | 2,268.6 | 150.1 | 10.6 | 5.4 | 92 | 4.2 | |
| 786.0 | 19,566.0 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.9 | 3.8 | |
| 961.8 | 15,505.2 | 8,279.6 | 397.8 | 9.9 | 6.4 | 38.9 | 2.2 | |
| 891.5 | 16,006.2 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.3 | 1.7 | |
| 1,740.9 | 20,522.2 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.5 | |
| 165.2 | 22,200.2 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 448.8 | 17,527.3 | 3,738.7 | 316.7 | 12.5 | 7.5 | 55.3 | 3.6 |
Shareholding Pattern
View DetailsNews & Analysis
All News
5 min read•By Research Desk
3 min read•By Research Desk
2 min read•By Research Desk
4 min read•By Research Desk
About Wockhardt
Wockhardt Limited, a pharmaceutical and biotech company, manufactures and markets pharmaceuticals, medicinal, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Mexico, Russia, and internationally. It... develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules; and active pharmaceutical ingredients. The company's biopharmaceutical products include Glaritus, a long-acting biosimilar glargine; Wosulin, a recombinant human insulin; Wepox, an r-DNA erythropoietin; human insulin; and Biovac-B, a hepatitis B vaccine. Its pipeline also includes rapid and long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, and delivery devices. In addition, the company provides contract manufacturing services. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India. Read more
-
Incorporated
1999
-
Chairman
Habil Khorakiwala
-
Managing Director
Murtaza Khorakiwala
-
Group
Wockhardt
-
Headquarters
Chhatrapati Sambhajinagar - (Aurangabad), Maharashtra
-
Website
Looking for more details about Wockhardt Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Wockhardt
What is the current share price of Wockhardt Ltd Today?
The share price of Wockhardt Ltd is ₹1,937.50 (NSE) and ₹1,943.85 (BSE) as of 08-Jun-2026 09:39 IST. Wockhardt Ltd has given a return of 124.98% in the last 3 years.
What is the current PB & PE ratio of Wockhardt Ltd?
The P/E ratio of Wockhardt Ltd is 146.48 times as on 05-Jun-2026, a 226 premium to its peers’ median range of 44.87 times.
The P/B ratio of Wockhardt Ltd is 6.31 times as on 05-Jun-2026, a 54 premium to its peers’ median range of 4.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
5.31
|
|
2024
|
0.00
|
2.69
|
|
2023
|
0.00
|
0.66
|
|
2022
|
0.00
|
0.99
|
|
2021
|
6.12
|
1.36
|
What is the 52 Week High and Low of Wockhardt Ltd?
The 52-week high and low of Wockhardt Ltd are Rs 2,422.30 and Rs 1,086.70 as of 08-Jun-2026.
What is the market cap of Wockhardt Ltd?
Wockhardt Ltd has a market capitalisation of ₹ 31,201 Cr as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Wockhardt Ltd?
Before investing in Wockhardt Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.